申请人:NOVO NORDISK AS
公开号:WO2001023347A1
公开(公告)日:2001-04-05
The present invention relates to novel compounds of general formula (I), pharmaceutical formulations comprising these compounds, the use of these compounds as medicaments, the use of these medicaments in the treatment of and/or prevention of diabetes, and especially non-insulin dependent diabetes (NIDDM or Type 2 diabetes) as well as methods for treating diabetes comprising administration of these compounds.